We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BRO's Organic Growth Hinges on New Business and Acquisitions
Read MoreHide Full Article
Key Takeaways
BRO's third-quarter organic revenues rose 1.2% year over year to $1.46 billion.
Retail organic revenues grew 2.6%, supported by new business, exposure growth and employee benefits.
Accession synergies target $175 million by 2028, while Specialty Distribution revenues declined 0.8%.
Brown & Brown, Inc. (BRO - Free Report) appears reasonably positioned to sustain organic revenue growth despite moderating insurance pricing, although a meaningful acceleration may remain challenging. Its diversified distribution network, specialty business portfolio, new business generation and cross-selling opportunities provide a foundation for growth. However, softer pricing across certain commercial insurance lines could limit commission expansion, increasing the importance of customer retention and exposure growth.
In the third quarter of 2026, BRO's organic revenues increased 1.2% year over year to $1.46 billion. Including contingent commissions, organic revenue growth was 1.5%. The Retail segment delivered 2.6% organic revenue growth to $854 million, supported by net new business, exposure-unit expansion and employee benefits and bond businesses. Employee benefits pricing remained favorable, with rates increasing 9-11%, while casualty rates rose 2-5%. These trends could continue to support organic growth.
However, Specialty Distribution organic revenues declined 0.8% to $610 million, reflecting softer wholesale market conditions and declining catastrophe and difference-in-conditions property rates. Weakness in standard property pricing could continue to constrain commission growth. Additionally, the company's adjusted EBITDAC margin contracted 200 basis points to 34.6%, highlighting potential operating margin pressures.
BRO's expanded distribution capabilities following the Accession acquisition offer opportunities to cross-sell products, deepen customer relationships and improve market penetration. Its increased Accession synergy target of $175 million by 2028 could also support profitability.
Overall, BRO has growth opportunities through new business, exposure expansion and acquisition synergies. However, sustained improvement across segments will be necessary to offset moderating pricing and wholesale market weakness. Thus, maintaining organic growth appears achievable, but accelerating it meaningfully in the near term could prove challenging.
What About Its Peers?
Arthur J. Gallagher & Co. (AJG - Free Report) appears better positioned to sustain organic revenue growth despite moderating insurance pricing. In the third quarter of 2026, its combined Brokerage and Risk Management segments delivered 5% organic revenue growth, supported by strong client retention, new business generation and expanding client exposures. Organic supplemental revenues increased 14%, while base commissions and fees grew 4%. Its diversified business mix, cross-selling opportunities and acquisition strategy should support growth. However, softer commercial insurance pricing could constrain commission expansion, making volume growth and client retention increasingly important.
Willis Towers Watson (WTW - Free Report) appears well positioned to sustain organic revenue growth despite moderating insurance pricing. In the third quarter of 2026, organic revenues increased 4%, supported by 5% growth in Risk & Broking and 4% growth in Health, Wealth & Career. Strong new business activity, client renewals, specialty insurance demand and technology sales supported performance. Its diversified consulting and brokerage businesses, alongside investments in AI and technology, should provide additional growth opportunities. However, softer commercial insurance pricing and competitive market conditions could constrain brokerage revenue expansion.
BRO’s Price Performance
BRO shares have lost 12.6% over the past year compared with the industry’s decline of 1.2%.
Image Source: Zacks Investment Research
BRO’s Undervaluation
The stock is undervalued compared with its industry. It is currently trading at a price-to-book value multiple of 1.86, lower than the industry average of 3.62.
Image Source: Zacks Investment Research
Estimate Movement for BRO
The Zacks Consensus Estimate for BRO’s fourth-quarter 2026 earnings has moved down 4.2% in the past 30 days. The same for the full-year 2026 and 2027 earnings per share has moved down 1.1% and 1.8%, respectively, in the past 30 days.
Image Source: Zacks Investment Research
The consensus estimate for BRO’s 2026 and 2027 EPS and revenues indicates a year-over-year increase.
View the Zacks #1 Rank List
Image: Bigstock
BRO's Organic Growth Hinges on New Business and Acquisitions
Key Takeaways
Brown & Brown, Inc. (BRO - Free Report) appears reasonably positioned to sustain organic revenue growth despite moderating insurance pricing, although a meaningful acceleration may remain challenging. Its diversified distribution network, specialty business portfolio, new business generation and cross-selling opportunities provide a foundation for growth. However, softer pricing across certain commercial insurance lines could limit commission expansion, increasing the importance of customer retention and exposure growth.
In the third quarter of 2026, BRO's organic revenues increased 1.2% year over year to $1.46 billion. Including contingent commissions, organic revenue growth was 1.5%. The Retail segment delivered 2.6% organic revenue growth to $854 million, supported by net new business, exposure-unit expansion and employee benefits and bond businesses. Employee benefits pricing remained favorable, with rates increasing 9-11%, while casualty rates rose 2-5%. These trends could continue to support organic growth.
However, Specialty Distribution organic revenues declined 0.8% to $610 million, reflecting softer wholesale market conditions and declining catastrophe and difference-in-conditions property rates. Weakness in standard property pricing could continue to constrain commission growth. Additionally, the company's adjusted EBITDAC margin contracted 200 basis points to 34.6%, highlighting potential operating margin pressures.
BRO's expanded distribution capabilities following the Accession acquisition offer opportunities to cross-sell products, deepen customer relationships and improve market penetration. Its increased Accession synergy target of $175 million by 2028 could also support profitability.
Overall, BRO has growth opportunities through new business, exposure expansion and acquisition synergies. However, sustained improvement across segments will be necessary to offset moderating pricing and wholesale market weakness. Thus, maintaining organic growth appears achievable, but accelerating it meaningfully in the near term could prove challenging.
What About Its Peers?
Arthur J. Gallagher & Co. (AJG - Free Report) appears better positioned to sustain organic revenue growth despite moderating insurance pricing. In the third quarter of 2026, its combined Brokerage and Risk Management segments delivered 5% organic revenue growth, supported by strong client retention, new business generation and expanding client exposures. Organic supplemental revenues increased 14%, while base commissions and fees grew 4%. Its diversified business mix, cross-selling opportunities and acquisition strategy should support growth. However, softer commercial insurance pricing could constrain commission expansion, making volume growth and client retention increasingly important.
Willis Towers Watson (WTW - Free Report) appears well positioned to sustain organic revenue growth despite moderating insurance pricing. In the third quarter of 2026, organic revenues increased 4%, supported by 5% growth in Risk & Broking and 4% growth in Health, Wealth & Career. Strong new business activity, client renewals, specialty insurance demand and technology sales supported performance. Its diversified consulting and brokerage businesses, alongside investments in AI and technology, should provide additional growth opportunities. However, softer commercial insurance pricing and competitive market conditions could constrain brokerage revenue expansion.
BRO’s Price Performance
BRO shares have lost 12.6% over the past year compared with the industry’s decline of 1.2%.
Image Source: Zacks Investment Research
BRO’s Undervaluation
The stock is undervalued compared with its industry. It is currently trading at a price-to-book value multiple of 1.86, lower than the industry average of 3.62.
Image Source: Zacks Investment Research
Estimate Movement for BRO
The Zacks Consensus Estimate for BRO’s fourth-quarter 2026 earnings has moved down 4.2% in the past 30 days. The same for the full-year 2026 and 2027 earnings per share has moved down 1.1% and 1.8%, respectively, in the past 30 days.
Image Source: Zacks Investment Research
The consensus estimate for BRO’s 2026 and 2027 EPS and revenues indicates a year-over-year increase.
BRO stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.